Page 30 - Morphosys Customs Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Morphosys customs inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Morphosys Customs Inc Today - Breaking & Trending Today

MorphoSys (NASDAQ:MOR) Shares Gap Up to $6.01

MorphoSys AG (NASDAQ:MOR – Get Rating)’s stock price gapped up before the market opened on Wednesday . The stock had previously closed at $6.01, but opened at $6.46. MorphoSys shares last traded at $6.50, with a volume of 110 shares changing hands. A number of research firms have recently commented on MOR. Zacks Investment Research […] ....

Morgan Stanley , Marshall Wace , Wells Fargo Company , Zacks Investment Research , Quadrant Capital Group , Us Bancorp , Get Rating , Investment Research , Capital Group , Wells Fargo , Proprietary Development , Partnered Discovery , Nasdaq Mor ,

MorphoSys AG: MorphoSys ranked Number One in Germany for Female Representation at Leadership Level in European Women on Boards' Gender Equality Index Report

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / January 24, 2022 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) was acknowledged as a Best Practice Leader in the European Women on Boards' Gender Equality Index Report, ranking ....

United States , Thomas Biegi , Julia Neugebauer , Jean Paul Kress , Myles Clouston , Jeanette Bressi , Exchange Commission , Us Communications , Best Practice Leader , European Women , Board Gender Equality Index Report , Boards Gender Equality Index Report , Gender Diversity Index , Morphosys Supervisory Board , Executive Committee , Morphosy Annual Report ,

MorphoSys AG: MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance

Preliminary 2021 Monjuvi U.S. net product sales of US$ 79.1 million ( € 66.9 million)Anticipated 2022 Monjuvi U.S. net product sales in the range of US$ 110 to 135 millionPLANEGG / MUNICH, GERMANY / ACCESSWIRE ....

United States , Thomas Biegi , Julia Neugebauer , Jean Paul Kress , Myles Clouston , Jeanette Bressi , Xencor Inc , Drug Administration , Us Communications , Exchange Commission , Chief Executive Officer , Antibody Dependent Cell Mediated Cytotoxicity , Antibody Dependent Cellular Phagocytosis , Morphosy Annual Report ,

MorphoSys AG: MorphoSys To Present At the 40th Annual J.P. Morgan Healthcare Conference

PLANEGG / MUNICH, GERMANY / ACCESSWIRE / Janauary 10, 2022 / MorphoSys AG (FSE:MOR; NASDAQ:MOR), announced today that Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys, will present at the 40 ....

United States , Thomas Biegi , Julia Neugebauer , Jean Paul Kress , Myles Clouston , Jeanette Bressi , Exchange Commission , Us Communications , Chief Executive Officer , Healthcare Conference , Wednesday January , Morphosy Annual Report ,

MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales

MARTINSRIED (dpa-AFX) - MorphoSys AG (MOR, MPSYY.PK) reported that preliminary Monjuvi U.S. net product sales were $23.6 million for the fourth quarter and $79.1 million for the full year 2021. ....

Jean Paul Kress , Chief Executive Officer ,